Mayukh Sukhatme, Pres&Chief Investment Officer at Roivant Sciences Ltd. (ROIV), sold 1,575,732 shares at $12.00 ($18.9M) on 2024-12-24, disclosed to the SEC on 2024-12-26.
Open-market sale of $18.9M ROIV by Pres&Chief Investment Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 10,796 | $130K | 0.7% |
| 2 | $12.00 | 185,946 | $2.2M | 11.8% |
| 3 | $12.01 | 689,495 | $8.3M | 43.8% |
| 4 | $12.01 | 689,495 | $8.3M | 43.8% |
| Total | $12.01 avg | 1,575,732 | $18.9M | 100% |
| Filing → |
| ROIV | SELL | 2026-06-29 | $34.1M | — | Filing → |
| ROIV | SELL | 2026-02-11 | $9.0M | — | Filing → |
| ROIV | SELL | 2025-12-31 | $57.8M | — | Filing → |